Navigation Links
Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer
Date:12/15/2009

KNOXVILLE, Tenn., Dec. 15 /PRNewswire/ -- Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer.

Following the success of its pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use. Via an inexpensive blood test, ColoMarker(TM) will detect colon cancer in its earliest, most curable stages.

"American Cancer Society statistics show that when colon cancer is detected in its early stages, more than 90% of patients will survive. If not detected until the later stages, fewer than 10% will survive. ColoMarker(TM) detects colon cancer in these early, highly curable stages," says Kevin Jones, Ph.D., Chief Scientific Officer of EDP.

According to American Cancer Society statistics, fewer than 20% of Americans over the age of 50 who should be screened for colon cancer, actually are. With the use of ColoMarker(TM), a simple and inexpensive blood test, the number of people being screened would likely increase dramatically, leading to a decline in deaths due to colon cancer.

In pre-clinical trials, ColoMarker(TM) successfully detected the early stages (I, II, and III) of colon cancer. In tests of 2,370 blood samples, ColoMarker(TM) showed an accuracy rate of >99% for detecting colon cancer in these early stages. "ColoMarker(TM) could lead to a radical shift in the way we detect colon cancer," adds Dr. Jones.

National researchers who study colorectal cancer are closely monitoring emerging technologies such as ColoMarker(TM). Their findings are encouraging; just last week, the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention and the North American Association of Central Cancer Registries released an optimistic report about the expected decline in deaths from colon cancer due to anticipated improvements in early screening methods.

Dr. Jones states, "The use of ColoMarker(TM) as a screening test could save tens of thousands of American lives every year and billions of dollars in healthcare costs." EDP Biotech is now moving forward expeditiously to get ColoMarker(TM) through the Food and Drug Administration clearance process.

For more information on ColoMarker(TM) or EDP Biotech Corporation, contact Jeff Hooper, Ackermann PR, and (865) 584-0550.

About EDP Biotech Corporation

EDP Biotech Corporation (EDP) is a medical device company focused on the development and sale of immunodiagnostic tests for both humans and animals. EDP utilizes more than 30 years of research and development in identification and purification of proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is Early Detection Products.


    Jeff Hooper
    Ackermann PR
    (865) 584-0550
    jhooper@ackermannpr.com

SOURCE EDP Biotech Corporation


'/>"/>
SOURCE EDP Biotech Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
2. Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries
3. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
4. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
5. Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis
6. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
7. Researchers Find High-Dose Therapy for Liver Disease Not Effective
8. Nucleix Researchers Discover DNA Evidence May Easily Be Falsified
9. Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
10. Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
11. Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Obstetrics ... company profile to their offering. ... addition of the "Global Obstetrics Partnering ... company profile to their offering. --> ...
(Date:2/4/2016)... , Feb. 4, 2016  The Senior Care ... Government Reform Committee Chairman Jason Chaffetz ... holding today,s hearing , "Developments in the ... increases and growing questions about abusive pharmacy benefit ... (R-UT) and Ranking Member Elijah Cummings (D-MD) ...
(Date:2/4/2016)... FOSTER CITY, Calif. , Feb. 4, 2016 ... (the "Company") today announced it has entered into ... and Exchange Commission (SEC) fully resolving the SEC,s ... Practices Act (FCPA).  Under the terms of the ... total of $12.8 million, including disgorgement, pre-judgment interest ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 2016 , ... Successful recruitment and retention efforts, new collaborations ... have all marked the last 12 months at Roswell Park Cancer Institute (RPCI). ... oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of her ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President ... have signed a joint enrollment and degree completion agreement. The agreement, which ... baccalaureate degrees at FHU|Dickson. , The agreement allows students to be jointly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to feel uncomfortable about ... than regular municipal or well water. The recent experience with lead contaminated water in ... a long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... (APDA) announced the election of Patrick McDermott as Chairman of the National Board of ... welcome Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA ...
(Date:2/5/2016)... ... ... In sleep, when the defenses of the day are at rest, rejected emotions ... disorders is significant self-criticism, and consequently these patients experience this disease with their feelings, ... for coping with this unease, but also leads to a reservoir of emotions that ...
Breaking Medicine News(10 mins):